Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7116-36-1

Post Buying Request

7116-36-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7116-36-1 Usage

General Description

3-(4-chloro-phenyl)-propionic acid ethyl ester is a chemical compound with the molecular formula C11H13ClO2. It is an ethyl ester derivative of 3-(4-chloro-phenyl)-propionic acid, which is a non-steroidal anti-inflammatory drug (NSAID) commonly used to relieve pain and inflammation. This chemical is widely utilized as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its chloro-phenyl group gives it potential for use as a pesticide, while its anti-inflammatory properties make it valuable for medicinal purposes. Additionally, it is a colorless and odorless liquid that is insoluble in water but soluble in organic solvents. Due to its potential medicinal and agricultural applications, 3-(4-chloro-phenyl)-propionic acid ethyl ester is an important compound in the fields of pharmaceuticals and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 7116-36-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,1 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7116-36:
(6*7)+(5*1)+(4*1)+(3*6)+(2*3)+(1*6)=81
81 % 10 = 1
So 7116-36-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H13ClO2/c1-2-14-11(13)8-5-9-3-6-10(12)7-4-9/h3-4,6-7H,2,5,8H2,1H3

7116-36-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-(4-chlorophenyl)propanoate

1.2 Other means of identification

Product number -
Other names Ethyl p-chlorohydrocinnamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7116-36-1 SDS

7116-36-1Relevant articles and documents

Selective hydrogenation of α,β-unsaturated carbonyl compounds on silica-supported copper nanoparticles

Mendes-Burak, Jorge,Ghaffari, Behnaz,Copéret, Christophe

supporting information, p. 179 - 181 (2019/01/04)

Silica-supported copper nanoparticles prepared via surface organometallic chemistry are highly efficient for the selective hydrogenation of various α,β-unsaturated carbonyl compounds yielding the corresponding saturated esters, ketones, and aldehydes in the absence of additives. High conversions and selectivities (>99%) are obtained for most substrates upon hydrogenation at 100-150 °C and under 25 bar of H2.

The unexpected kinetic effect of enzyme mixture: The case of enzymatic esterification

Zysk, Malgorzata,Zadlo, Anna,Brodzka, Anna,Wisniewska, Catalina,Ostaszewski, Ryszard

, p. 225 - 229 (2014/04/03)

During the studies towards synthesis of carboxylic acids esters, using ethyl carbonate and carboxylic acid as substrates, we found that different single enzyme systems provide model ethyl 3-phenylpropanoate in very low yield. Systematic studies proved tha

2-IMIDAZOLINES

-

Page/Page column 22, (2009/01/24)

The present invention relates to compounds of formula I wherein X—Y, R1, and n are as defined herein and to their pharmaceutically active salts. Compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1 and are useful for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7116-36-1